Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-001776

Options or other derivatives

  • Director acquired 20,275 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shacham Sharon · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,275 20,275 D
Loading xslF345X05/form4.xml…